Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation

European Journal of Pharmacology

Volumn 363, Issue 1, 1998, Pages 57-63

  Costantino, Giuseppina ^a   Cuzzocrea, Salvatore ^a   Mazzon, Emanuela ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Melatonin; Nitric oxide (NO); Oedema; Peroxynitrite; Zymosan activated plasma

Indexed keywords

MELATONIN; NITRIC OXIDE; PEROXYNITRITE; SCAVENGER; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; EDEMA; INFLAMMATION; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FOOT; FREE RADICAL SCAVENGERS; MALE; MELATONIN; NITRATES; OXIDANTS; PLASMA; RATS; RATS, WISTAR; TYROSINE;

EID: 0032436255     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00673-6     Document Type: Article

References (54)

1. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
2. Bertuglia S., Marchiafava P.L., Colantuoni A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc. Res. 31:1996;947-952.
3. Bettahi I., Pozo O.D., Osuna C., Reiter R.J., Acuna-Castroviejo D., Guerrero J.M. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20:1996;205-210.
4. Cuzzocrea S., Zingarelli B., Calapai G., Nava F., Caputi A.P. Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci. 60:1997;215-220.
5. Cuzzocrea S., Filippelli A., Zingarelli B., Falciani M., Caputi A.P., Rossi F. Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock. 7:1997;351-357.
6. Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L., Caputi A.P., Szabò C. Role of peroxynitrite and activation of Poly (ADP Ribose) synthetase in the vascular failure induced by zymosan-activated plasma. Br. J. Pharmacol. 122:1997;493-503.
7. Cuzzocrea S., Zingarelli B., Gilard E., Hake P., Salzman A.L., Szabò C. Protective effect of melatonin in carrageenan-induced models of local inflammation. J. Pineal Res. 23:1997;106-116.
8. Cuzzocrea S., Zingarelli B., Costantino G., Szabó A., Salzman A.L., Caputi A.P., Szabó C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121:1997;1065-1074.
9. Cuzzocrea, S., Costantino, G., Zingarelli, B., Caputi, A.P., 1998a. Protective effects of poly (ADP-ribose) synthase inhibitor in zymosan-activated plasma induces paw oedema. Life Sci., in press.
10. Cuzzocrea S., Zingarelli B., Costantino G., Caputi A.P. Protective effect of melatonin in a non septic shock model induced by zymosan in the rat. J. Pineal Res. 25:1998;24-33.
11. Cuzzocrea S., Costantino G., Caputi A.P. Protective effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-Ribose) synthetase activation in a non septic shock model induced by zymosan in the rat. J. Pineal Res. 25:1998;78-85.
12. Cuzzocrea S., Zingarelli B., Gilard E., Hake P., Salzman A.L., Szabó C. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Rad. Biol. Med. 24:1998;450-459.
13. Da Motta J.I., Cunha F.Q., Vargaftig B.B., Ferreira S.H. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion. Br. J. Pharmacol. 112:1994;111-116.
14. Daniels W.M.U., Reiter R.J., Melchiorri D., Sewerynek E., Plablos M.I., Ortiz G.G. Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6-phosphatase activity. J. Pineal Res. 19:1996;1-6.
15. Di Rosa M., Willoughby D.A. Screens for anti-inflammatory drugs. J. Pharm. Pharmacol. 23:1971;297-300.
16. Di Rosa M., Giroud J.P., Willoughby D.A. Studies of mediators of the acute inflammatory response induced in rats in different site by carrageenin and turpentine. J. Pathol. 104:1971;15-21.
17. 5a anaphylatoxins: evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo condition. J. Immunol. 120:1978;109-115.
18. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A.L., Szabò C. Melatonin is a scavenger of peroxinitrite. Life Sci. 60:1997;PL169-PL174.
19. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J. 12:1998;685-693.
20. Giusti P., Lipartiti M., Franceschini D., Schiavo N., Floreani M., Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10:1996;891-896.
21. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., Moncada S. Peroxynitrite modification of low density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330:1993;18-25.
22. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;177-186.
23. Lancaster J.R. Jr. Nitric oxide in cells. Am. Sci. 80:1992;248-255.
24. 51Cr -labeled cells and myeloperoxidase Inflammation. 7:1983;247-254.
25. Maestroni G.J.M. Melatonin as a therapeutical agent in experimental endotoxic shock. J. Pineal Res. 20:1996;84-89.
26. Marshall K.A., Reiter R.J., Poeggeler B., Aruoma O.I., Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Rad. Biol. Med. 21:1996;307-315.
27. Mehta J.L., Lawson D.L., Nicolini F.A., Ross M.H., Player D.W. Effects of activated polimorphonuclear leucocytes on vascular smooth muscle tone. Am. J. Physiol. 261:1991;H327-H334.
28. Melchiorri G., Reiter R.J., Attia A.M., Hara M., Burgos A., Nisticò G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:1994;83-89.
29. Menemdez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Walden L.R., Pablos M.I., Tan D.X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53:1994;373-382.
30. Mohan N., Sadeghi K., Reiter R.J., Meltz M.L. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem. Mol. Biol. Int. 37:1995;1063-1070.
31. Mullane K.M., Kraemer R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Meth. 14:1985;157-167.
32. Murohara T., Kugyyama K., Sugiyama S., Ohgushi M., Yasue H. Activated human polymorphonuclear leucocytes elicit endothelium-dependent contraction in isolated pig coronary arteries. J. Cardiovasc. Pharmacol. 21:1993;760-766.
33. Nava F., Calapai G., Facciolà G., Cuzzocrea S., Giuliani G., De Sarro A., Caputi A.P. Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. Eur. J. Pharmacol. 331:1997;267-274.
34. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
35. Pentney P.T., Bubenik G.A. Melatonin reduces the severity of dextran-induced colitis in mice. J. Pineal Res. 19:1995;31-39.
36. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:1994;271-277.
37. Pierpaoli W., Regelson W. Pineal control of aging: effects of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA. 91:1994;787-793.
38. Pozo D., Reiter R.J., Calvo J.R., Guerrero J.M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 55:1994;PL455-PL460.
39. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interaction. Endocrine Rev. 12:1991;151-156.
40. Reiter R.J. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem. Int. 27:1995;453-460.
41. Reiter R.J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G.G., Acuna-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
42. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269:1994;26066-26071.
43. Salvemini D., Wang Z.Q., Bourdon D.M., Stern M.K., Currie M.G., Manning P.T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur. J. Pharmacol. 303:1996;217-220.
44. Salvemini D., Wang Z.Q., Wyatt D.M., Bourdon M.H., Marino P.T., Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118:1996;829-838.
45. Sewerynek E., Abe M., Reiter R.J., Barlow-Walden L.R., Chen L., McCabe T.J., Roman L.J., Diaz-Lopez B. Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J. Cell. Biochem. 58:1995;436-444.
46. Sewerynek E., Reiter R.J., Melchiorri D., Ortiz G.G., Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepato-Gastroenterology. 43:1996;898-905.
47. Szabó C. The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock. 6:1996;79-88.
48. Tan D.X., Chen L.D., Poeggeller B., Manchester L.C., Reiter R.J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-62.
49. Teixeira T.J., Williams P.G., Hellewell P.G. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. 110:1993;416-422.
50. Thiemermann C., Bowes J., Mynny F.P., Vane J.R. Inhibition of the activity of poly(ADP ribose) synthase reduces ischaemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 94:1997;679-683.
51. G-monomethylarginine, reduces carrageenan-induced pleurisy in the rat. J. Pharmacol. Exp. Ther. 273:1995;1295-1299.
52. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.W. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
53. Zingarelli B., O'Connor M., Wong H., Salzman A.L., Szabó C. Peroxynitrite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:1996;350-358.
54. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., Szabó C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of Poly (ADP-ribose) synthetase. Cardiovasc. Res. 36:1997;205-215.